Ziolkowski Jennifer Lynn

Chief Financial Officer, DirectorVigil Neuroscience, Inc. (VIGL) · full profile →Form 4 · filed Aug 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
1 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 5, 2025Disposed to issuer(D)4K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 5, 2025Disposed to issuer(D)156K0
Aug 5, 2025Disposed to issuer(D)22K0
Aug 5, 2025Disposed to issuer(D)96K0
Aug 5, 2025Disposed to issuer(D)120K0
Aug 5, 2025Disposed to issuer(D)50K0
Aug 5, 2025Disposed to issuer(D)110K0
Aug 5, 2025Disposed to issuer(D)135K0
Aug 5, 2025Disposed to issuer(D)156K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-102496) within minutes of acceptance. Every field above traces to the original document. Verify it directly: